Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 18,778 | 17,826 | 16,637 | 10,781 | 9,079 |
| Operating Income | -18,778 | -17,826 | -16,637 | -10,781 | -9,079 |
| Other Income | 2,439 | 2,152 | 2,663 | 1,915 | 1,377 |
| Pre-tax Income | -16,339 | -15,674 | -13,974 | -8,866 | -7,702 |
| Net Income Continuous | -16,339 | -15,674 | -13,974 | -8,866 | -7,702 |
| Net Income | $-16,339 | $-15,674 | $-13,974 | $-8,866 | $-7,702 |
| EPS Basic Total Ops | -4.40 | -4.20 | -3.80 | -2.50 | 4.10 |
| EPS Basic Continuous Ops | -4.42 | -4.20 | -3.76 | -2.48 | 4.15 |
| EPS Diluted Total Ops | -4.40 | -4.20 | -3.80 | -2.50 | 4.10 |
| EPS Diluted Continuous Ops | -4.42 | -4.20 | -3.76 | -2.48 | 4.15 |
| EBITDA(a) | $-18,506 | $-17,582 | $-16,424 | $-10,538 | $-8,912 |